1. Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns

Browsing by Author National Cancer Center Hospital East

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
1-Jan-2013Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito; Osaka University; Osaka National Hospital; Aichi Cancer Center Hospital and Research Institute; National Cancer Center Hospital East; Gunma University Hospital; Prince of Songkla University; Mahidol University; Tokai University; Tokyo Metropolitan Komagome Hospital; Kumamoto University; Osaka Medical Center for Cancer and Cardiovascular Diseases; National Shikoku Cancer Center Hospital; Korea Cancer Center Hospital; National Kyushu Cancer Center; Sagara Hospital; Yonsei University College of Medicine; Novartis Pharmaceuticals Corporation; Cancer Institute Hospital of Japan Foundation for Cancer Research
1-Apr-2022Human Papillomavirus 16 E6 Suppresses Transporter Associated with Antigen-Processing Complex in Human Tongue Keratinocyte Cells by Activating Lymphotoxin PathwayAti Burassakarn; Pensiri Phusingha; Takashi Yugawa; Kazuma Noguchi; Tipaya Ekalaksananan; Patravoot Vatanasapt; Tohru Kiyono; Chamsai Pientong; Faculty of Tropical Medicine, Mahidol University; Faculty of Medicine, Khon Kaen University; National Cancer Center Research Institute; National Cancer Center Hospital East; Hyogo Medical University
1-May-2022Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048Danny Rischin; Kevin J. Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Irene Braña; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G.M. Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey Long Hong; René Gonzalez Mendoza; Liyi Jia; Diana Chirovsky; Josephine Norquist; Fan Jin; Barbara Burtness; Ramathibodi Hospital; Vall d‘Hebron Institut de Oncologia; Oslo Universitetssykehus; National Taiwan University Hospital; Peter Maccallum Cancer Centre; Universiti Malaya; Ethnikó ke Kapodistriakó Panepistímio Athinón; Royal Brisbane and Women's Hospital; UniversitatsSpital Zurich; Yale School of Medicine; The Royal Marsden NHS Foundation Trust; Paracelsus Medizinische Privatuniversitat; Medizinische Universität Wien; National Cancer Center Hospital East; Centre Hospitalier de L'Universite de Montreal; Universidade de São Paulo; Merck & Co., Inc.; University of Kansas Medical Center; Hospital Duran i Reynals; Centro Estatal de Cancerológia de Chihuahua
23-Nov-2019Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 studyBarbara Burtness; Kevin J. Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Neus Basté; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G.M. Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey Long Hong; René González Mendoza; Ananya Roy; Yayan Zhang; Burak Gumuscu; Jonathan D. Cheng; Fan Jin; Danny Rischin; Guillermo Lerzo; Marcelo Tatangelo; Mirta Varela; Juan Jose Zarba; Michael Boyer; Hui Gan; Bo Gao; Brett Hughes; Girish Mallesara; Anne Taylor; Martin Burian; Carlos Henrique Barrios; Dalvaro Oliveira de Castro Junior; Gilberto Castro; Fabio Andre Franke; Gustavo Girotto; Iane Pinto Figueiredo Lima; Ulisses Ribaldo Nicolau; Gustavo Dix Junqueira Pinto; Lucas Santos; Ana Paula Victorino; Neil Chua; Felix Couture; Richard Gregg; Aaron Hansen; John Hilton; Joy McCarthy; Denis Soulieres; Rodrigo Ascui; Pablo Gonzalez; Luis Villanueva; Marco Torregroza; Angela Zambrano; Petra Holeckova; Zdenek Kral; Bohuslav Melichar; Jana Prausova; Milan Vosmik; Maria Andersen; Niels Gyldenkerne; Hannes Jurgens; Kadri Putnik; Petri Reinikainen; Viktor Gruenwald; Simon Laban; Gerasimos Aravantinos; Ioannis Boukovinas; Vassilis Georgoulias; Dora Kwong; Yousuf Al-Farhat; Tibor Csoszi; Jozsef Erfan; Geza Horvai; Laszlo Landherr; Eva Remenar; Agnes Ruzsa; Judit Szota; Salem Billan; Iris Gluck; Orit Gutfeld; Aron Popovtzer; Marco Benasso; Simona Bui; Vittorio Ferrari; Lisa Licitra; Franco Nole; Takashi Fujii; Yasushi Fujimoto; Nobuhiro Hanai; Hiroki Hara; Koji Matsumoto; Kenji Mitsugi; Nobuya Monden; Masahiro Nakayama; Kenji Okami; Nobuhiko Oridate; Oslo University Hospital; National Taiwan University Hospital; Peter Maccallum Cancer Centre; University of Malaya; Royal Brisbane and Women's Hospital; University of Melbourne; UniversitatsSpital Zurich; Yale School of Medicine; Royal Marsden NHS Foundation Trust; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Attikon University Hospital; Paracelsus Medizinische Privatuniversitat; Hospital Universitari Vall d'Hebron; Hospital Universitari de Bellvitge; Medizinische Universitat Wien; National Cancer Center Hospital East; Centre Hospitalier de L'Universite de Montreal; Merck & Co., Inc.; University of Kansas Medical Center; Cancer Cluster Salzburg; Instituto do Câncer do Estado de São Paulo; Unidad de Investigación en Salud de
Showing results 1 to 4 of 4